[Myocardial infarction and depression: clinical-functional relationships and possibilities of correction of left ventricular remodeling with antidepressant tianeptine].
Vasiuk
Iu A
IuA
Lebedev
A V
AV
Dovzhenko
T V
TV
Semiglazova
M V
MV
D000700:Analgesics; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use*; D003863:Depression / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D013318:Stroke Volume / Q000502:physiology; D013841:Thiazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects* / Q000502:physiology; D020257:Ventricular Remodeling / Q000187:drug effects* / Q000502:physiology
D000700:Analgesics; D000929:Antidepressive Agents, Tricyclic; D013841:Thiazepines; C050504:tianeptine